摘要:
A bearing assembly comprises a bearing enabling a rotatable body to rotate about a rotational axis relative to a stationary body. The bearing includes a bearing inner ring and a bearing outer ring, each having at least first and second roller body tracks provided in or on non-parallel surfaces of the ring. The respective roller body tracks of the bearing outer ring are aligned with the respective roller body tracks of the bearing inner ring and a row of roller bodies is disposed between each of the respective sets of roller body tracks. At least one of the rows of roller bodies comprises one of tapered rollers and spherical rollers, at least one of the rows of roller bodies supports at least axial forces and at least one of the rows of the roller bodies supports at least radial forces.
摘要:
A bearing assembly comprises a bearing enabling a rotatable body to rotate about a rotational axis relative to a stationary body. The bearing includes a bearing inner ring and a bearing outer ring, each having at least first and second roller body tracks provided in or on non-parallel surfaces of the ring. The respective roller body tracks of the bearing outer ring are aligned with the respective roller body tracks of the bearing inner ring and a row of roller bodies is disposed between each of the respective sets of roller body tracks. At least one of the rows of roller bodies comprises one of tapered rollers and spherical rollers, at least one of the rows of roller bodies supports at least axial forces and at least one of the rows of the roller bodies supports at least radial forces.
摘要:
The present invention relates to compounds of formula I, The compounds of formula I are valuable pharmacologically active compounds. They exhibit a strong anti-thrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardio-vascular disorders like thromboembolic diseases or restenoses. They are inhibitors of the blood clotting enzymes, especially factor VIIa and can in general be applied in conditions in which an undesired activity of factor VIIa is present or for the cure or prevention of which an inhibition of factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
摘要:
The invention therefore relates to compounds of the formula I in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.
摘要:
Pyrimidine-4,6-dicarboxylic acid diamides of the formula I are suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerative joint diseases.
摘要:
The use of bissulfonamides for producing medicines for the treatment of hyperlipidemia. The invention relates to the use of bissulfonamides and their salts for producing medicines for the treatment of hyperlipidemia. The use of compounds of formula I in which the radicals have the stated meanings, and of their salts for producing a medicine for the treatment of hyperlipidemia is described.
摘要:
Sulfonylcarboxamide derivatives of formula I, their physiologically acceptable salts and/or physiologically functional derivatives, methods of making these compounds, their use for preparing medicines for the prevention and treatment of hyperlipidemia and arteriosclerotic disorders. The compounds of formula I have the following structure: in which the radicals are as defined and their physiologically acceptable salts and physiologically functional derivatives are described.
摘要:
New phenylsulfonyloxybenzimidazolecarbamates of the formula ##STR1## are described, as are processes for their preparation. The new compounds have anthelmintic activity, including, in particular, against liver flukes.
摘要:
3-Carbalkoxyamino-1H-2,1,4-benzothiadiazine derivatives are disclosed as well as a process for their manufacture. The compounds are suitable for combatting helminths and especially gastrointestinal Strongylides and liver flukes.
摘要:
The present invention relates to triazinobenzimidazoles and to a process for their preparation.The compounds are chemotherapeutics and are suitable for combating parasitary diseases in humans and animals; they are especially active against nematodes.